Company Filing History:
4 out of 1,935 
3 out of 896 
2 out of 290 
Years Active: 2016-2020
Title: Vasyl Sava: Innovator in Granulocyte Colony-Stimulating Factor Research
Introduction
Vasyl Sava is a notable inventor based in Wesley Chapel, FL (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of granulocyte colony-stimulating factor (G-CSF) receptors. With a total of 4 patents, his work has the potential to impact treatments for various neurodegenerative diseases.
Latest Patents
Sava's latest patents focus on small molecules that mimic or antagonize the actions of G-CSF. These compounds are designed for the modulation of the G-CSF receptor and may function as agonists, antagonists, or mixed/partial agonists/antagonists. The patents also detail methods for treating conditions, including neurodegenerative diseases, by administering these innovative compounds.
Career Highlights
Throughout his career, Vasyl Sava has worked with esteemed institutions such as the University of South Florida and the United States Government as represented by the Department of Veterans Affairs. His research has contributed to advancements in understanding and treating conditions related to G-CSF.
Collaborations
Some of his notable coworkers include Juan Sanchez-Ramos and Shijie Song, who have collaborated with him on various research projects.
Conclusion
Vasyl Sava's innovative work in the field of G-CSF research highlights his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of neurodegenerative diseases.